{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:58:29Z","timestamp":1794484709187,"version":"4.9.1"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>In patients with systemic sclerosis (SSc), vascular manifestations precede skin and organ fibrosis. There is increasing evidence demonstrating a pathogenic link between early vascular injury and subsequent development of tissue fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Our knowledge of cellular and molecular mechanisms underlying a unique relationship between SSc-related vasculopathy and fibrosis has changed over the last few years. There is increasing evidence showing viral infection as a potential trigger elucidating vascular injury. Due to defective vascular repair machinery, this initial event results in endothelial cell activation and apoptosis as well as the recruitment of inflammatory\/immune cells, leading to endothelial-to-mesenchymal transition. This sequential process induces destructive vasculopathy in capillaries, fibroproliferative vascular lesions in arteries, and excessive fibrosis in the surrounding tissue. A variety of molecular mechanisms and pathways involved in vascular remodeling linked to subsequent excessive fibrosis have been identified and serve as attractive therapeutic targets for SSc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Endothelial injury may play a central role in connecting three features that characterize SSc pathogenesis: vasculopathy, chronic inflammation, and fibrosis. Our understanding of the processes responsible for myofibroblast differentiation triggered by vascular injury will provide the rationale for novel targeted therapies for SSc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000959","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T13:01:21Z","timestamp":1690290081000},"page":"309-316","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":33,"title":["Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis"],"prefix":"10.1097","volume":"35","author":[{"given":"Yasushi","family":"Kawaguchi","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5301\/jsrd.5000249","article-title":"Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities","volume":"2","author":"Varga","year":"2017","journal-title":"J Scleroderma Rel Disord"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.5152\/eurjrheum.2019.19081","article-title":"The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis","volume":"7","author":"Rosa","year":"2020","journal-title":"Eur J Rheumatol"},{"issue":"(Suppl 3)","key":"R7-20250526","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.5152\/eurjrheum.2019.19158","article-title":"Endothelial cells and endothelial progenitor cells in the pathogenesis of systemic sclerosis","volume":"7","author":"Ota","year":"2020","journal-title":"Eur J Rheumatol"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3389\/fimmu.2018.02045","article-title":"Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: Should the door be closed?","volume":"9","author":"Bruni","year":"2018","journal-title":"Front Immunol"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0000000000000830","article-title":"New mechanism-based approaches to treating and evaluating the vasculopathy of scleroderma","volume":"33","author":"Flavahan","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"R10-20250526","first-page":"821","article-title":"Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins","volume":"27","author":"Vaughan","year":"2000","journal-title":"J Rheumatol"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"651013","DOI":"10.3389\/fimmu.2021.651013","article-title":"Innate immune modulation induced by EBV lytic infection promotes endothelial cell inflammation and vascular injury in scleroderma","volume":"12","author":"Farina","year":"2021","journal-title":"Front Immunol"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.0303-6987.2003.0143.x","article-title":"Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma","volume":"3","author":"Magro","year":"2004","journal-title":"J Cutan Pathol"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000232945","article-title":"Human parvovirus B19 (B19\u200aV) infection in systemic sclerosis patients","volume":"52","author":"Zakrzewska","year":"2009","journal-title":"Intervirology"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1093\/rheumatology\/keaa230","article-title":"Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis","volume":"59","author":"Arvia","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.55563\/clinexprheumatol\/ret1kg","article-title":"Increased expression of interferon regulated and antiviral response genes in CD31+\/CD102+ lung microvascular endothelial cells from systemic sclerosis patients with end-stage interstitial lung disease","volume":"39","author":"Piera-Velazquez","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0394632015572750","article-title":"From microvasculature to fibroblasts: contribution of antiendothelial cell antibodies in systemic sclerosis","volume":"28","author":"Corallo","year":"2015","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1093\/rheumatology\/keac594","article-title":"Autoimmune activation and hypersensitization of the AT1 and ETA receptors contributes to vascular injury in scleroderma renal crisis","volume":"62","author":"Hegner","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"103310","DOI":"10.1016\/j.autrev.2023.103310","article-title":"Autoantibodies targeting G protein-coupled receptors: an evolving history in autoimmunity. Report of the 4th international symposium","volume":"22","author":"Cabral-Marques","year":"2023","journal-title":"Autoimmun Rev"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"935787","DOI":"10.3389\/fimmu.2022.935787","article-title":"Autoimmunity to sphingosine-1-phosphate-receptors in systemic sclerosis and pulmonary arterial hypertension","volume":"13","author":"Gluschke","year":"2022","journal-title":"Front Immunol"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/3-540-36028-X_6","article-title":"Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis","volume":"176","author":"Fischer","year":"2006","journal-title":"Handb Exp Pharmacol"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jid.2019.11.026","article-title":"Decreased CCN3 in systemic sclerosis endothelial cells contributes to impaired angiogenesis","volume":"140","author":"Henrot","year":"2020","journal-title":"J Invest Dermatol"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s13075-014-0442-z","article-title":"Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features","volume":"16","author":"Cipriani","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1073\/pnas.1813006116","article-title":"Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma","volume":"116","author":"Tsou","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"e12440","DOI":"10.1111\/micc.12440","article-title":"Microvascular involvement in systemic sclerosis and systemic lupus erythematosus","volume":"26","author":"Saygin","year":"2019","journal-title":"Microcirculation"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trsl.2019.02.010","article-title":"Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis","volume":"209","author":"Korman","year":"2019","journal-title":"Transl Res"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.37705","article-title":"Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)\/transforming growth factor \u03b2-dependent mesenchymal-to-mesenchymal transition","volume":"65","author":"Serrat\u00ec","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","article-title":"Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis","volume":"76","author":"Manetti","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"(Suppl 3)","key":"R32-20250526","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.5152\/eurjrheum.2019.19081","article-title":"The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis","volume":"7","author":"Rosa","year":"2020","journal-title":"Eur J Rheumatol"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41569-018-0023-y","article-title":"Reassessing endothelial-to mesenchymal transition in cardiovascular diseases","volume":"15","author":"Li","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.3390\/jcm5040045","article-title":"Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of human fibrotic diseases","volume":"5","author":"Piera-Velazquez","year":"2016","journal-title":"J Clin Med"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ajpath.2015.03.019","article-title":"Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension","volume":"185","author":"Good","year":"2015","journal-title":"Am J Pathol"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.matbio.2016.01.012","article-title":"Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of systemic sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?","volume":"51","author":"Jimenez","year":"2016","journal-title":"Matrix Biol"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.39421","article-title":"Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease","volume":"68","author":"Mendoza","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.3389\/fimmu.2018.02191","article-title":"Single cell RNA sequencing identifies HSPG2 and APLNR as markers of endothelial cell injury in systemic sclerosis skin","volume":"9","author":"Apostolidis","year":"2018","journal-title":"Front Immunol"},{"key":"R39-20250526","first-page":"610","article-title":"New insights into profibrotic myofibroblast formation in systemic sclerosis: when the vascular wall becomes the enemy","volume":"11","author":"Romano","year":"2021","journal-title":"Life (Basel)"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"826839","DOI":"10.3389\/fphar.2022.826839","article-title":"Contributions of immune cells and stromal cells to the pathogenesis of systemic sclerosis: recent insights","volume":"13","author":"Dai","year":"2022","journal-title":"Front Pharmacol"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cei.13599","article-title":"Endothelial-to-mesenchymal transition in systemic sclerosis","volume":"205","author":"Di Benedetto","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor \u03b2 -at the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3899\/jrheum.150088","article-title":"The endothelial-mesenchymal transition in systemic sclerosis is induced by endothelin-1 and transforming growth factor-\u03b2 and may be blocked by macitentan, a dual endothelin-1 receptor antagonist","volume":"42","author":"Cipriani","year":"2015","journal-title":"J Rheumatol"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jdermsci.2021.06.009","article-title":"Bone morphogenetic protein-7 inhibits endothelial-to-mesenchymal transition in primary human umbilical vein endothelial cells and mouse model of systemic sclerosis via Akt\/mTOR\/p70S6K pathway","volume":"103","author":"Shen","year":"2021","journal-title":"J Dermal Sci"},{"key":"R45-20250526","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jid.2022.08.052","article-title":"Reduced SPAG17 expression in systemic sclerosis triggers myofibroblast transition and drives fibrosis","volume":"143","author":"Sapao","year":"2023","journal-title":"J Invest Dermatol"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"110189","DOI":"10.1016\/j.celrep.2021.110189","article-title":"CXCL4 drives fibrosis by promoting several key cellular and molecular processes","volume":"38","author":"Affandi","year":"2022","journal-title":"Cell Rep"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13075-020-02266-0","article-title":"The role of the oncostatin M\/OSM receptor \u03b2 axis in activating dermal microvascular endothelial cells in systemic sclerosis","volume":"22","author":"Marden","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3389\/fimmu.2018.01985","article-title":"Potential link between oxidative stress and endothelial-to-mesenchymal transition in systemic sclerosis","volume":"19","author":"Thuan","year":"2018","journal-title":"Front Immunol"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/rheumatology\/kez159","article-title":"Autophagy mediates 2-methoxyestradiol-inhibited scleroderma collagen synthesis and endothelial-to-mesenchymal transition induced by hypoxia","volume":"58","author":"Liu","year":"2019","journal-title":"Rheumatology"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.41192","article-title":"Promotion of myofibroblast differentiation and tissue fibrosis by the leukotriene B4-leukotriene B4 receptor axis in systemic sclerosis","volume":"72","author":"Liang","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4049\/jimmunol.1800883","article-title":"Macrophages guard endothelial lineage by hindering endothelial-to-mesenchymal transition: implications for the pathogenesis of systemic sclerosis","volume":"203","author":"Nicolosi","year":"2019","journal-title":"J Immunol"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"104669","DOI":"10.1016\/j.isci.2022.104669","article-title":"Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation","volume":"25","author":"Kim","year":"2022","journal-title":"iScience"},{"key":"R54-20250526","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/18755666MTE18MDU4x","article-title":"The role of pro-fibrotic myofibroblasts in systemic sclerosis: from origin to therapeutic targeting","volume":"22","author":"Romano","year":"2021","journal-title":"Curr Mol Med"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"e160977","DOI":"10.1172\/jci.insight.160977","article-title":"SARA suppresses myofibroblast precursor transdifferentiation in fibrogenesis in a mouse model of scleroderma","volume":"7","author":"Corano Scheri","year":"2022","journal-title":"JCI Insight"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"H613","DOI":"10.1152\/ajpheart.00220.2020","article-title":"Metabolism of vascular smooth muscle cells in vascular diseases","volume":"319","author":"Shi","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R57-20250526","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5301\/jsrd.5000218","article-title":"The isolation and characterization of systemic sclerosis vascular smooth muscle cells: enhanced proliferation and apoptosis resistance","volume":"1","author":"Altorok","year":"2016","journal-title":"J Scleroderma Relat Disord"},{"key":"R58-20250526","first-page":"75","article-title":"Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro","volume":"8","author":"Svegliati","year":"2017","journal-title":"Front Immunol"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-016-1122-y","article-title":"Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study","volume":"18","author":"Corallo","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R60-20250526","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5301\/jsrd.5000204","article-title":"Effect of endothelin-1 receptor antagonists on skin fibrosis in scleroderma patients from the EUSTAR database","volume":"1","author":"Jordan","year":"2016","journal-title":"J Scleroderma Relet Disord"},{"key":"R61-20250526","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/art.27466","article-title":"Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis","volume":"62","author":"Seibold","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"(Suppl 1)","key":"R62-20250526","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.rmed.2016.08.022","article-title":"Antifibrotic effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence","volume":"122","author":"Sandner","year":"2017","journal-title":"Respir Med"},{"key":"R63-20250526","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/annrheumdis-2019-216823","article-title":"Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial","volume":"79","author":"Khanna","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R64-20250526","doi-asserted-by":"crossref","first-page":"SI125","DOI":"10.1093\/rheumatology\/keac433","article-title":"Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells","volume":"62","author":"Romano","year":"2023","journal-title":"Rheumatology"},{"key":"R65-20250526","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.1002\/anie.201302588","article-title":"The chemistry and biology of soluble guanylate cyclase stimulators and activators","volume":"52","author":"Follmann","year":"2013","journal-title":"Angew Chem Int Ed Engl"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T17:21:13Z","timestamp":1748280073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000959","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]}}}